2003D-0206 - Draft Guidance for Industry on Exocrine Pancreatic Insufficiency Drug Products--Submitting New Drug Application; Availability
FDA Comment Number : EC13
Submitter : Dr. Robert Beall Date & Time: 07/12/2004 12:07:46
Organization : Cystic Fibrosis Foundation
Consumer Group
Category :
Issue Areas/Comments
GENERAL
GENERAL
Please see attached file.